The goal of this study is to understand how exogenous kisspeptin affects metabolism by evaluating responses to an oral glucose tolerance test
Assignment: Each study subject will serve as their own control. The order of the visits will be randomized. Delivery of Interventions: * Prior to the study visit, subjects will undergo a review of their medical history and screening laboratories. * During the inpatient study, the subjects will * Undergo a 16-hour kisspeptin infusion * Undergo an oral glucose tolerance test
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
16
Administration of a 75 gm oral glucose tolerance test
Intravenous administration of kisspeptin 112-121 x 16 hours
Intravenous administration of Placebo 16 hours
Massachusetts General Hospital
Boston, Massachusetts, United States
Oral Glucose Sensitivity Index (Kisspeptin-Placebo)
Change in Oral glucose Sensitivity Index between kisspeptin and placebo arms in oral glucose tolerance test
Time frame: 3 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.